Early menopause has several possible causes, ranging from genetics and autoimmune conditions to cancer treatments, surgery, and environmental exposures. Menopause that occurs between ages 40 and 45 is classified as early menopause, affecting about 5% of women. When it happens before age 40, it’s called premature menopause or primary ovarian insufficiency (POI). Understanding the specific trigger matters because it shapes both the health risks involved and the options available.
Genetic Causes
Some women are genetically predisposed to run out of viable eggs sooner. One well-studied example involves mutations in the FMR1 gene, which cause a condition called Fragile X-associated primary ovarian insufficiency (FXPOI). In a healthy version of this gene, a specific DNA segment repeats 5 to 40 times. In women with FXPOI, that segment repeats 55 to 200 times. This overexpansion causes the gene to produce abnormally high levels of a particular RNA molecule, which appears to interfere with proteins essential for ovarian function. Women with FXPOI go through menopause an average of five years earlier than women without the condition, and the mutation is inherited through the X chromosome.
Chromosomal conditions like Turner syndrome, where one X chromosome is missing or partially missing, can also lead to ovarian insufficiency. Family history is one of the strongest predictors: if your mother or sisters went through menopause early, your risk is significantly higher.
Autoimmune Conditions
The immune system can mistakenly target the ovaries, destroying the follicles that produce eggs and hormones. This autoimmune ovarian damage is most clearly documented in women with Addison’s disease (primary adrenal insufficiency), roughly 10% of whom develop premature ovarian failure. The link is even stronger in autoimmune polyglandular syndromes, which are conditions where multiple glands come under immune attack simultaneously. In the most severe form (APS-1), 45 to 60% of affected women develop ovarian failure.
Hypothyroidism is the single most common autoimmune condition associated with early menopause, whether it’s Hashimoto’s disease or Graves’ disease. But the list extends well beyond the thyroid. Type 1 diabetes, celiac disease, lupus, rheumatoid arthritis, Crohn’s disease, and Sjögren’s syndrome have all been observed alongside autoimmune ovarian failure. If you have one autoimmune condition and notice your periods becoming irregular or stopping, that combination is worth bringing to your doctor’s attention.
Chemotherapy and Radiation
Cancer treatments are among the most direct medical causes of early menopause. Chemotherapy drugs, particularly alkylating agents, work by damaging DNA inside rapidly dividing cells. Ovarian cells are highly vulnerable to this process. The drugs create breaks in the DNA strands of both the eggs themselves and the surrounding support cells. When the damage is too severe for the cell’s built-in repair systems to fix, those cells die. The result is a depleted egg supply that may never recover.
Pelvic radiation is similarly destructive. Eggs are extraordinarily sensitive to radiation: the dose needed to destroy half of a woman’s follicles is less than 2 Gray, a relatively low threshold in radiation oncology. Radiation damages ovarian tissue both directly, by breaking DNA strands, and indirectly, by generating reactive oxygen species that overwhelm the cells’ natural defenses.
The ovarian damage from both chemotherapy and radiation follows a dose-dependent pattern. Higher cumulative doses cause more follicle loss. In some cases, menstrual periods return after treatment ends, particularly in younger women with a larger initial egg reserve. But even when cycles resume, the overall egg supply is reduced, which can lead to menopause years earlier than it would have occurred naturally.
Surgical Menopause
Removing both ovaries (bilateral oophorectomy) causes immediate menopause regardless of age. What normally unfolds gradually over 5 to 10 years in natural menopause happens all at once. In one study, women’s estradiol levels plummeted from an average of about 165 pg/mL before surgery to just 15 pg/mL within three months, staying at that level permanently. The hormonal shift is so abrupt that symptoms like hot flashes, sleep disruption, and mood changes tend to be more intense than in natural menopause.
Even a hysterectomy that preserves the ovaries can accelerate the timeline. Removing the uterus may compromise blood flow to the ovaries, potentially causing them to lose function earlier than they otherwise would. The effect isn’t as dramatic or immediate as oophorectomy, but it’s a recognized contributor.
Smoking
Smoking is the most well-documented lifestyle factor that pushes menopause earlier. Current smokers face nearly twice the risk of early menopause compared to women who have never smoked. The relationship is sharply dose-dependent. Women who have smoked 20 or more pack-years (the equivalent of a pack a day for 20 years, or two packs a day for 10) have more than double the risk of never-smokers.
Quitting helps, but the benefit depends on how much damage has already accumulated. Former smokers with 10 or fewer pack-years have a risk similar to never-smokers. But those who smoked more heavily before quitting still carry an elevated risk. Timing also matters: women who were still smoking at age 35, even moderately, had a significantly higher risk of early menopause than those who quit before then. The chemicals in cigarette smoke are directly toxic to ovarian follicles, accelerating the rate at which the egg supply is used up.
Environmental Toxins
A growing body of evidence links certain industrial chemicals to earlier menopause. These substances, broadly called endocrine disruptors, interfere with the hormonal signaling that keeps the ovaries functioning.
- PFAS (per- and polyfluoroalkyl substances): Found in nonstick cookware, food packaging, and water supplies. Women with the highest PFAS exposure reach menopause about two years earlier than women with the lowest exposure, based on data from a major U.S. women’s health study.
- Phthalates: Common in plastics, personal care products, and food containers. Women with the highest urinary phthalate levels went through menopause 3 to nearly 4 years earlier than those with the lowest levels, according to national health survey data.
- Pesticides: Older organochlorine pesticides like DDT, though largely banned in the U.S., persist in the environment and in body fat. Women with the highest blood levels of DDT reached menopause nearly 6 years earlier than those with the lowest levels.
- PCBs (polychlorinated biphenyls): Industrial chemicals banned decades ago but still present in soil, water, and older buildings. High PCB levels were associated with menopause arriving 2 to nearly 4 years earlier.
These chemicals are difficult to avoid entirely because they’re widespread in the food supply, drinking water, and consumer products. Reducing exposure where possible, such as filtering drinking water, avoiding heating food in plastic containers, and choosing fragrance-free personal care products, may lower cumulative exposure over time.
How Early Menopause Is Confirmed
A blood test measuring follicle-stimulating hormone (FSH) is the primary diagnostic marker. FSH levels above 30 mIU/mL, combined with at least 12 months of missed periods, generally confirm that the ovaries have stopped functioning. Your body produces more FSH when the ovaries aren’t responding, essentially sending a louder and louder signal trying to trigger egg release.
Another marker called anti-Müllerian hormone (AMH) reflects the remaining egg supply and may detect declining ovarian function earlier than FSH. However, AMH testing isn’t yet standardized enough to be considered routine in most clinical settings.
Long-Term Health Risks
Early menopause isn’t just about fertility or managing symptoms. Losing estrogen earlier means losing its protective effects on the heart and bones for a longer stretch of life. Research from Northwestern University found that women who enter natural menopause before age 40 face about a 40% higher lifetime risk of coronary heart disease compared to women who go through menopause later. That increased risk held true even after adjusting for other cardiovascular risk factors like smoking, obesity, high blood pressure, and diabetes, and it was consistent across racial groups.
Bone density also declines faster without estrogen. The earlier menopause begins, the more years of accelerated bone loss accumulate before a woman reaches the age when fracture risk climbs steeply. This is why women who experience early or premature menopause are typically offered hormone therapy not just for symptom relief, but specifically to protect cardiovascular and bone health during the years their bodies would normally still be producing estrogen.